CAS 822-12-8

sodium tetradecanoate

Codes：MIRI-004

Application context (from source-drug indications)

肝细胞癌米铂水合物

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
米铂水合物Miriplatin Hydrate	Tier C — Watch / trade	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

米铂水合物原研路线steps: 3total yield: /

cyclohexane-1,2-diamine→Platinum, dichloro(1,2-cyclohexanediamine-kN1,kN2)-, (SP-4-2)-→MIRI-003→sodium tetradecanoate

米铂水合物工艺路线steps: 3total yield: 12.6 g

sodium tetradecanoate→(1R,2R)-cyclohexane-1,2-diamine→MIRI-008→MIRI-009

米铂水合物工艺路线steps: 3total yield: 13.2 g

sodium tetradecanoate→(1R,2R)-cyclohexane-1,2-diamine→MIRI-010

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.